Revium Rx. (RVRC)
OTCMKTS · Delayed Price · Currency is USD
1.670
+0.170 (11.33%)
At close: Mar 30, 2026

Revium Rx. Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2009
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '09
101322352431
Market Cap Growth
276054.11%35.91%-55.43%20.71%5974.83%-
Enterprise Value
98272452441
Last Close Price
1.670.520.401.501.4915.00
PS Ratio
-----1.08
PB Ratio
16.474.591.1837.45110.750.82
P/TBV Ratio
93.5617.465.5637.45110.75-
P/FCF Ratio
-----0.22
P/OCF Ratio
-----0.22
EV/Sales Ratio
-----1.37
EV/FCF Ratio
-35.95----0.28
Debt / Equity Ratio
0.030.020-0.000.23
Debt / FCF Ratio
-----0.06
Net Debt / Equity Ratio
-0.32-0.38-0.27-0.86-1.090.23
Net Debt / EBITDA Ratio
0.570.751.481.190.36-
Net Debt / FCF Ratio
0.731.034.351.170.520.06
Asset Turnover
-----0.16
Quick Ratio
1.402.039.248.066.240.07
Current Ratio
1.622.269.589.326.530.41
Return on Equity (ROE)
-105.91%-101.17%-33.23%-110.77%--2.97%
Return on Assets (ROA)
-15.63%-15.15%-20.42%-62.04%--1.61%
Return on Capital Employed (ROCE)
-55.70%-50.00%-18.10%-72.00%-305.40%-9.70%
Earnings Yield
-13.35%-42.59%-15.09%-1.89%-2.81%-14.59%
FCF Yield
-2.68%-8.04%-5.22%-1.95%-1.91%454.66%
Buyback Yield / Dilution
-48.92%-136.92%12.69%-4.44%-48170.60%15.69%